Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OneMedNet (ONMD) Net Income towards Common Stockholders (2022 - 2025)

OneMedNet has reported Net Income towards Common Stockholders over the past 4 years, most recently at -$3.1 million for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 12.65% to -$3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Dec 2025, up 68.39% year-over-year, with the annual reading at $34000.0 for FY2025, 140.96% up from the prior year.
  • Net Income towards Common Stockholders was -$3.1 million for Q4 2025 at OneMedNet, down from -$741000.0 in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $2.8 million in Q2 2025 and troughed at -$33.5 million in Q4 2022.
  • The 4-year median for Net Income towards Common Stockholders is -$1.4 million (2023), against an average of -$4.9 million.
  • Year-over-year, Net Income towards Common Stockholders plummeted 69481.23% in 2024 and then surged 176.82% in 2025.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at -$33.5 million in 2022, then increased by 1.58% to -$32.9 million in 2023, then soared by 91.67% to -$2.7 million in 2024, then dropped by 12.65% to -$3.1 million in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Net Income towards Common Stockholders are -$3.1 million (Q4 2025), -$741000.0 (Q3 2025), and $2.8 million (Q2 2025).